Ärztin für Psychiatrie und Psychotherapie
Dipl. prozessorientierte Psychotherapeutin ASP
Winterthur · Berlin
Let's Talk About Sex
- What challenges have you faced in bringing a pill for women in menopause to market?
- Why the FDA rejected Addyi twice
- The Big Pink Fight for the Little Pink Pill
- What does finally receiving FDA approval for Addyi in post-menopausal women mean for women’s health?
- it’s harder for me to become aroused
- Overdose/Missed Dose
- i don’t have sexual thoughts anymore
Discomfort with women naming dissatisfaction and demanding solutions. Fear sits at the center of this discomfort. Fear that sexual agency disrupts traditional hierarchies. Fear that a woman who claims her own pleasure might also claim her own economic and political independence.
What challenges have you faced in bringing a pill for women in menopause to market?
At its core, the documentary is about power. It is about who gets to define health, who gets to claim pleasure, and who benefits when women are told to stay quiet about their bodies. Women all wonder, “What happened to me?” Men always get listened to. Women are dismissed and made to feel wrong for even asking the question. Directed by Aisling Chin-Yee and premiering at DOC NYC, the film follows entrepreneur Cindy Eckert’s decade-long struggle to win FDA approval for Addyi, the drug frequently labeled “female Viagra.” The nickname is catchy.
Incidence not known
More than twenty medications for male erectile dysfunction have been approved with relative efficiency. Addyi was stalled, scrutinized, and moralized for years. Why do we want horny women running around? You want to throttle the lot as you watch. From the beginning, the film establishes the central injustice. Fear that equality in the bedroom signals equality everywhere.
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Kamagra Gold | 100 mg | 120 + 6 Pills | 330.74€ 314.99€ | |
| Cialis Generic | 2.5mg | 90 + 6 Pills | 112.43€ 107.08€ | |
| Kamagra Oral Jelly | 100 mg | 21 Sachets | 95.92€ 91.35€ | |
| Cialis Generic | 60mg | 60 + 4 Pills | 145.06€ 138.15€ | |
| Tadalista Super Active | 20mg | 270 + 30 Pills | 661.49€ 629.99€ | |
| Viagra Generic | 150mg | 30 + 2 Pills | 72.32€ 68.88€ | |
| Cialis Generic | 5mg | 360 + 10 Pills | 268.08€ 255.31€ | |
| Cialis Original | 20mg | 34 + 2 Pills | 183.99€ 175.23€ | |
| Viagra Generic | 100mg | 270 + 10 Pills | 270.47€ 257.59€ | |
| Cialis Soft Tabs | 20mg | 20 + 2 Pills | 66.98€ 63.79€ | |
| Kamagra Polo | 100mg | 180 + 8 Pills | 446.52€ 425.26€ |
Outspoken and unapologetic in her trademark pink, she confronts regulators and critics head-on. She marshals advocacy groups and public pressure to expose, as she frames it, gender bias at the FDA.
Why the FDA rejected Addyi twice
Female pleasure outside those boundaries is framed as indulgent, destabilizing, even sinful. Throughout history, many religious doctrines have treated women’s sexuality as something to regulate. Modesty codes, purity culture, and rigid gender roles are not fringe ideas. They are embedded in institutions that shape law and policy. The recent rise of right-leaning political movements has amplified these frameworks. When Addyi finally won approval in 2015, the victory felt seismic.
- The pink pill can improve blood flow, leading to increased arousal.
- It may help with vaginal dryness or discomfort during intimacy.
- Psychological factors, like stress, also influence its effectiveness.
- Combining with counseling or therapy can enhance results.
It is proof that persistence can pierce institutional inertia. Yet the film does tadalista tablets not end in triumph alone.
- The pink pill aims to boost women's libido and sexual satisfaction.
- It often contains ingredients like aphrodisiacs or hormonal components.
- Some pink pills are marketed as supplements; others are pharmaceutical drugs.
- Effectiveness varies; consult a healthcare provider before use.
It shows how the drug’s subsequent corporate handling undercut accessibility, how political shifts darkened the broader landscape of rights, and how the battle for bodily autonomy is never isolated. Reproductive freedom, sexual health, workplace equality, and economic independence are interconnected. Chin-Yee expands the narrative beyond Eckert. Doctors and scientists challenge the long-standing dismissal of female hypoactive sexual desire disorder. Women speak candidly about losing libido and feeling erased.
The Big Pink Fight for the Little Pink Pill
The idealized “tradwife” narrative celebrates domestic submission, childbearing, and withdrawal from public power. Against that backdrop, a drug designed to enhance female desire becomes more than medicine. The Pink Pill makes clear that resistance to Addyi was not solely about clinical data. Discomfort with the idea that women might seek sex for pleasure rather than obligation. Discomfort with acknowledging that female libido is not automatically extinguished by age, motherhood, or long-term partnership. Their testimonies are radical precisely because they are ordinary. Critics who argue that HSDD is over-medicalized appear as well. Instead, it asks who historically has had the authority to define women’s experiences as real or fabricated. Too often, that authority has rested in male-dominated institutions shaped by cultural and religious norms that prize control over autonomy. The film’s core message is direct: Female pleasure is fundamental to health, dignity, and equality, not a trivial matter. When political leaders legislate reproductive limits and religious authorities preach submission, the underlying logic is similar. Women’s bodies are communal property to be governed, not individual domains to be inhabited.
What does finally receiving FDA approval for Addyi in post-menopausal women mean for women’s health?
Footage of the 2016 election, the reshaping of the Supreme Court, and the fall of Roe v Wade is not incidental. As the political right has gained power, reproductive rights have narrowed. Conversations about contraception and bodily autonomy have become battlegrounds. Movements that seek to limit women’s control over reproduction often also resist conversations about female desire. In conservative and religious circles, sexuality is frequently tethered to procreation and marriage. The Pink Pill exposes how that logic infiltrates science, medicine, and law. It shows how breakthroughs in understanding female sexual response are met not just with skepticism but with attempts to contain them. In illuminating these patterns, the film becomes more than a chronicle of one drug. Gains in gender equity are not guaranteed. They can be reframed as threats to social order. Witty, incisive, and unapologetically provocative, The Pink Pill demands that viewers confront the hypocrisy of a culture that celebrates male virility while policing female desire. It challenges the rising chorus of voices that seek to return women to narrower roles under the banner of tradition or faith. And it insists that acknowledging women as full sexual beings is not radical.
| Type | Main Ingredients | Targeted Issue | Availability |
|---|---|---|---|
| Herbal Pink Pill | Ginseng, Rhodiola, Maca | Energy and libido enhancement | Over-the-counter supplements |
| Hormonal Pink Pill | Low-dose estrogen, vitamins | Hormonal imbalance, menopause | Prescription required |
| Herbal-Plus Pink Pill | Combination of herbs and vitamins | General wellness | Supplements, online stores |
| Sleep-support Pink Pill | Melatonin, valerian root | Sleep disorders | Pharmacies, herbal stores |
In the end, the pink pill is not just about libido. It is about whether society is willing to accept that women’s pleasure carries weight. That it is not a problem to be suppressed, but a reality to be understood. The fear exposed in this film is real.
- Pink pills are sometimes associated with the "pink economy" in sexual health.
- They are popular among women seeking discreet, quick solutions.
- Not all pink pills are evidence-based; some rely heavily on marketing claims.
- Consulting a healthcare professional is essential before starting any supplement.
So is the resolve of those who refuse to be silenced. Addyi is a nonhormonal medicine that works differently than Viagra by balancing brain chemical messengers that may be responsible for the lowered sex drive in some women.
it’s harder for me to become aroused
Male sexual performance is erectile dysfunction tablets uk framed as essential to identity. If a man cannot perform, it is treated as a crisis of masculinity and a medical emergency. If a woman cannot orgasm, feels pain during intercourse, or loses desire, she is told it is normal. It exposes how medical education and healthcare institutions have long sidelined women’s sexual needs. These same systems have aggressively funded and fast-tracked drugs for men.
Who should not use Addyi?
The film shows regulators raising concerns that women might become drowsy and fall asleep while driving children to school. The subtext is unmistakable: a woman’s primary role is caretaker. Her pleasure is secondary and deeply suspect. What makes the documentary especially urgent is its timing. Chin-Yee situates Eckert’s fight within a broader political shift. It is not used to enhance sexual performance or approved for use in men or children. Erectile dysfunction drugs like Viagra (sildenafil) or Cialis (tadalafil) increase smooth muscle relaxation and the inflow of blood to the spongy tissue in the penis to cause an erection.
- The term "pink pill" is often used metaphorically for gender-specific health solutions.
- Ongoing research aims to develop more effective, safe female libido enhancers.
- Cultural acceptance of such pills varies globally, affecting accessibility.
- Awareness about female sexual health continues to grow, driving demand.
Addyi is known by the generic name flibanserin and is approved by the FDA to treat acquired, generalized hypoactive sexual desire disorder (HSDD), or low libido, in both premenopausal and postmenopausal women less than 65 years of age characterized by low sexual desire that causes marked distress or interpersonal difficulty and is not due to: a co-existing medical or mental health condition the effects of a medication or other drug substance.
Overdose/Missed Dose
Pharmacists had to take a test to fill it. Women prescribed Addyi had to sign a pledge that they would not drink alcohol. (Viagra, on the other hand, came with a recommendation that one merely should avoid alcohol.) Faced with declining sales, Valeant more than doubled the price of Addyi, to $800 a prescription, making the drug cost-prohibitive. Then, in 2017, they shelved it altogether. What had once been the promising frontier in female sexual health was now essentially locked away.
How can I get more information about Addyi?
“How can you possibly pass something that is so wonderful for women and then have it ripped out?” says Gattuso in the film. “After all of this work, all of this emotion, we’re down to square one again. Eckert managed to buy Addyi back from Valeant and start over. The drug is back on the market – though, if you google it, the first thing you will read is still a bold warning about side effects. Addyi proponents see a seriously stubborn double standard. HSDD is acquired if you previously had normal sexual desires, and it's generalized when your low libido occurs no matter the sexual activity or partner.
i don’t have sexual thoughts anymore
There are 26 drugs approved for male sexual dysfunction, Chin-Yee noted, in part because no drug fits all. “That’s obvious, but for this drug and for women, it’s like, ‘well, if this could be a potential side effect, then the risk isn’t worth the benefit,’” she said. “And the benefit is only that women might enjoy their sex better. You know how many drugs come with nausea and dizziness and headaches? Those are things that pretty much every drug has on the side of their box.” The through line, she emphasized, is choice.
The Evidence Is Underwhelming at Best
“You should be able to have that discussion with your own body and your own physician, rather than somebody just removing it as an option for you.” The film puts that pursuit of pleasure in context with a very different medical landscape than when Addyi first premiered, a post-Roe world in which women’s reproductive rights are under assault, healthcare for trans people is criminalized and bodily autonomy across the board remains tenuous. Whether for abortion or orgasm, there’s nothing diminutive or inconsequential about choice, the film concludes. “You might think it’s funny and frivolous to say that women enjoying sex with their husbands is necessary,” said Chin-Yee. “But it is exactly that right being taken away that is related to all the other rights that could be taken away from you, and are being removed in the United States right now.” The Pink Pill is now available on Paramount+ The Pink Pill is now available on Paramount+ There is a reason the fight over a small pink pill feels so enormous. On its surface, The Pink Pill: Sex, Drugs & Who Has Control chronicles the battle to bring a medication for women’s low sexual desire to market. In addition, your low libido must also cause marked distress or an interpersonal difficulty. HSDD is the most common type of female sexual dysfunction, affecting roughly 6 million premenopausal women in the U.S. Addyi is classified a non-hormonal, multifunctional serotonin agonist antagonist (MSAA).